RxDoctor Payments Data

Jennifer Proffitt, PA

Physician Assistant · Lubbock, TXNPI 1013365634

Payments from drug & device makers

$4,708in general payments, 2019–2025

Across 296 payments — averaging $15.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$895
  • AbbVie$642
  • Boehringer Ingelheim$420
  • Pfizer$352
  • Bayer$220
  • Astellas Pharma US Inc$218
  • plus $2K from 28 others

What the payments were for

  • Food & beverage$4,63398%
  • Education$752%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$4,708 in reported general payments places this provider in the 85th percentile of 8,308 physician assistant providers in Texas.

See all physician assistant providers in Texas

Medicare billing

Part B allowed, 2024
$25,587
Medicare patients
159
Services billed
626

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide25$37,904
JardianceEmpagliflozin24$28,835
EliquisApixaban15$22,180
Breztri AerosphereBudesonide/Glycopyr/Formoterol19$12,163
Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog11$10,525
JanuviaSitagliptin Phosphate13$10,242
SymbicortBudesonide/Formoterol Fumarate16$4,178
Memantine Hcl26$2,570
Albuterol Sulfate HfaAlbuterol Sulfate45$1,331
Atorvastatin Calcium166$1,225
Azelastine Hcl42$1,125
Omeprazole69$1,074
Duloxetine Hcl34$1,003
Gabapentin59$975
Pregabalin25$939

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$895$37,90425 claims
Boehringer IngelheimJardiance$420$28,83524 claims
PfizerEliquis$352$22,18015 claims
AstraZenecaBreztri Aerosphere, Symbicort$131$16,34135 claims
MerckJanuvia$20$10,24213 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 8,308 physician assistant providers in Texas.

Other physician assistant in Lubbock

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →